WestEnd Advisors’s ResMed RMD Stock Holding History

WestEnd Advisors’s Portfolio RMD Stock Details RMD Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q2	$780	Hold	4	–	–	﹤0.01%	305
2026 Q1	$898	Hold	4	–	–	﹤0.01%	245
2025 Q4	$963	Hold	4	–	–	﹤0.01%	242
2025 Q3	$1.09K	Sell	4 -2	-33%	-$546	﹤0.01%	220
2025 Q2	$1.55K	Hold	6	–	–	﹤0.01%	172
2025 Q1	$1.34K	Buy	6 +4	+200%	+$934	﹤0.01%	185
2024 Q4	$457	Hold	2	–	–	﹤0.01%	185
2024 Q3	$488	Hold	2	–	–	﹤0.01%	175
2024 Q2	$383	Hold	2	–	–	﹤0.01%	186
2024 Q1	$396	Hold	2	–	–	﹤0.01%	172
2023 Q4	$344	Hold	2	–	–	﹤0.01%	187
2023 Q3	$296	Buy	+2	New	+$362	﹤0.01%	198
2023 Q1	–	Sell	-2	Closed	-$434	–	162
2022 Q4	$416	Hold	2	–	–	﹤0.01%	161
2022 Q3	$0	Hold	2	–	–	﹤0.01%	296
2022 Q2	$419	Buy	+2	New	+$426	﹤0.01%	147
2022 Q1	–	Sell	-1	Closed	-$242	–	211
2021 Q4	$260	Buy	+1	New	+$259	﹤0.01%	228
2021 Q3	–	Hold	0	–	–	–	211
2021 Q2	–	Hold	0	–	–	–	222

Other funds holding RMD

BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return

Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM

Vanguard Portfolio Management Malvern, Pennsylvania $2.22T AUM

State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return

Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return

Bank of New York Mellon New York $609B AUM 40.19% 1-Year Est. Return

First Trust Advisors Wheaton, Illinois $170B AUM 46.21% 1-Year Est. Return

Invesco Atlanta, Georgia $1.26T AUM 61.52% 1-Year Est. Return

Morgan Stanley New York $1.89T AUM 35.08% 1-Year Est. Return

Northern Trust Chicago, Illinois $860B AUM 41.15% 1-Year Est. Return

WestEnd Advisors's RMD Position: Q2 2026 in Review

WestEnd Advisors held its ResMed (RMD) position steady in Q2 2026 at 4 shares worth $780. The position accounts for ﹤0.01% of the portfolio, ranked #305.

WestEnd Advisors first reported a position in RMD in Q4 2021 and has held it in 16 quarters since. The position peaked at $1.55K in Q2 2025. 887 funds tracked by Wall St. Rank hold RMD as of Q2 2026.

WestEnd Advisors held 4 shares of ResMed worth $780 as of Q2 2026.
WestEnd Advisors left its ResMed share count unchanged in Q2 2026.
ResMed made up ﹤0.01% of WestEnd Advisors's portfolio in Q2 2026, its #305 holding.
WestEnd Advisors first reported a position in ResMed in Q4 2021 and has held it in 16 quarters since.
WestEnd Advisors's ResMed position peaked at $1.55K in Q2 2025.
887 funds tracked by Wall St. Rank held ResMed as of Q2 2026.

Based on WestEnd Advisors's 13F filing for Q2 2026, filed 22 Jul 2026.